Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15.
No abstract available

MeSH terms

  • Betacoronavirus
  • COVID-19
  • COVID-19 Drug Treatment
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / virology
  • Drug Repositioning*
  • Evidence-Based Medicine*
  • Health Services Needs and Demand
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Hydroxychloroquine

Associated data

  • ClinicalTrials.gov/NCT04315948
  • EudraCT/2020-000982-18